Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency

Evidence on the cost-effectiveness of newborn screening (NBS) for severe combined immunodeficiency (SCID) in the Australian policy context is lacking. In this study, a pilot population-based screening program in Australia was used to model the cost-effectiveness of NBS for SCID from the government p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Sophy T. F., Keller, Elena, Wiley, Veronica, Wong, Melanie, Farrar, Michelle A., Chambers, Georgina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326549/
https://www.ncbi.nlm.nih.gov/pubmed/35892474
http://dx.doi.org/10.3390/ijns8030044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326549/
https://www.ncbi.nlm.nih.gov/pubmed/35892474
http://dx.doi.org/10.3390/ijns8030044

Ejemplares similares